You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,323,948


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,323,948
Title:Asparaginases and uses thereof
Abstract: The present invention relates to an asparaginase having the width of the pH activity profile which is at least 3.5. Furthermore the invention relates to newly identified asparaginase polypeptide according to any one of SEQ ID NO: 2 or SEQ ID NO: 4 and to variants thereof and to polynucleotide sequences that encode such novel asparaginase variants. Furthermore the invention relates to the use of these novel asparaginase variants in industrial processes.
Inventor(s): Van Der Laan; Jan Metske (Breda, NL), Stor; Mark Cristiaan (Gouda, NL), De Lange; Ilse (Hellevoetsluis, NL), Mohrmann; Lisette (Bergschenhoek, NL)
Assignee: DSM IP Assets B.V. (Heerlen, NL)
Application Number:13/137,597
Patent Claims:1. An isolated asparaginase which is: a) a polypeptide the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4; or b) a polypeptide which has at least 90% identity with a polypeptide according to a).

2. An asparaginase according to claim 1 wherein a polypeptide regarding SEQ ID NO: 2 according to b) comprises one or more of Ala at position 25, Thr at position 28, Tyr at position 30, Ser at position 35, Leu at position 53, Ser at position 63, Ala at position 64, Asp at position 65, Asn at position 66, Ala at position 74, Be at position 77, Ile at position 79, Gln at position 80, Thr at position 81, Glu at position 88, Pro at position 106, Val at position 108, Ser at position 111, Leu at position 114, Ala at position 117, Thr at position 119, Glu at position 122, Asp at position 126, Ser at position 131, Val at position 161, Ala at position 168, Gln at position 181, Pro at position 189, Ala at position 190, Leu at position 197, Val at position 205, Phe at position 208, Ala at position 210, Ser at position 211, Val at position 224, Asn at position 228, Ala at position 231, Be at position 232, Val at position 233, Lys at position 236, Tyr at position 238, Tyr at position 240, Thr at position 250, Thr at position 251, Val at position 252, Val at position 254, Arg at position 255, Ser at position 259, Tyr at position 267, Gln at position 270, Gln at position 273, Ser at position 279, Asp at position 282, Asn at position 283, Lys at position 286, Ser at position 293, Ser at position 297, Ser at position 299, Gly at position 301, Ser at position 303, Asp at position 304, Asp at 307, Ile at position 309, Ala at position 310, Ser at position 311, Lys at position 312, His at position 313, Ser at position 314, Ile at position 317, Leu at position 319, Thr at position 321, Gly at position 324, Thr at position 330, Phe at position 345, Ala at position 351, Ala at position 360, Glu at position 361, Gly at position 364, Phe at position 365, Lys at position 366, Arg at position 369, Glu at position 370, Lys at position 374, Val at position 375 or Val at position 377, said positions being defined with reference to SEQ ID NO: 2.

3. An asparaginase according to claim 1 wherein a polypeptide regarding SEQ ID NO: 4 according to b) comprise one or more of Ser at position 356, Leu at position 53, Ser at position 63, Ala at position 64, Asp at position 65, Asn at position 66, Ala at position 74, Be at position 77, Ile at position 79, Gln at position 80, Thr at position 81, Glu at position 88, Pro at position 1066, Val at position 108, Ser at position 111, Leu at position 114, Ala at position 117, Thr at position 119, Glu at position 122, Asp at position 126, Val at position 161, Ala at position 168, Gln at position 181, Pro at position 189, Ala at position 190, Leu at position 197, Val at position 205, Phe at position 208, Ser at position 211, Val at position 224, Asn at position 228, Ala at position 231, Be at position 232, Val at position 233, Lys at position 236, Tyr at position 238, Thr at position 250, Thr at position 251, Val at position 254, Arg at position 255, Ser at position 259, Tyr at position 267, Gln at position 270, Asp at position 279, Asp at position 282, Asn at position 283, Lys at position 286, Ser at position 293, Ser at position 297, Ser at position 299, Ser at position 300, Gly at position 301 , Ser at position 303, Asp at position 304, Be at position 309, Ser at position 311, Thr at position 312, His at position 313, Ser at position 314, Ile at position 317, Thr at position 321, Gly at position 324, Pro at position 330, Glu at position 333, Gln at position 336, Phe at position 341, Ala at position 356, Gly at position 360, Glu at position 362, Arg at position 365, Glu at position 366, Lys at position 370, Val at position 371, Gly at position 372 or Val at position 373, said positions being defined with reference to SEQ ID NO: 4.

4. An asparaginase according to claim 1 which has a pH optimum between 6 and 7 and/or which has a specific activity at pH of at least 5 which is higher in comparison to the specific activity of the wild-type asparaginase from A. niger as disclosed in WO 2004/030468 measured under the same conditions.

5. An asparaginase according to claim 1 having the width of the pH activity profile which is at least 3.5 pH units wide.

6. An asparaginase according to claim 1 having the width of the pH activity profile which is at least 4, pH units wide.

7. A composition comprising the asparaginase according to claim 1.

8. A food product comprising the asparaginase according to claim 1.

9. The food product according to claim 8, which is thermally processed, and wherein the asparaginase reduces the amount of acrylamide formed in the thermally processed food product.

10. Process for the production of a food product involving at least one heating step, comprising adding one or more asparaginase enzymes according to claim 1 to an intermediate form of said food product in said production process whereby the enzyme is added prior to said heating step in an amount that is effective in reducing the level of asparagine that is present in said intermediate form of said food product.

11. A food product obtainable by the process according to claim 10.

12. A medicament comprising the asparaginase according to claim 1.

13. The asparaginase according to claim 1, wherein component b) is a polypeptide which has at least 95% identity with a polypeptide according to a).

14. An asparaginase according to claim 1 having the width of the pH activity profile which is at least 5 pH units wide.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.